 EDEN PRAIRIE, Minn., April 19, 2022 GLOBE NEWSWIRE -- Miromatrix Medical Inc. NASDAQ: MIRO, a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients lives, announced that CEO Jeff Ross will present at the 2022 Cell Gene Meeting on the Mediterranean. The conference, held this year on April 20 22 in Barcelona, Spain, brings together the leading public and private sector companies in the field of advanced therapies. 